| Literature DB >> 22493334 |
Peter-Michael Rath1, Fuat Saner, Andreas Paul, Nils Lehmann, Eike Steinmann, Jan Buer, Joerg Steinmann.
Abstract
This prospective study evaluated the utility of the SeptiFast (SF) test in detecting 25 clinically important pathogens in 225 blood samples from 170 intensive care unit (ICU) patients with suspected sepsis after liver transplantation (LTX) or after other major abdominal surgery (non-LTX). SF yielded a significantly higher positivity rate in the LTX group (52.3%) than in the non-LTX group (30.5%; P = 0.0009). SF may be a powerful tool for the early diagnosis of bloodstream infections in LTX patients.Entities:
Mesh:
Year: 2012 PMID: 22493334 PMCID: PMC3372100 DOI: 10.1128/JCM.00745-12
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948